498 related articles for article (PubMed ID: 27526275)
21. β-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Smith JR; Barber KE; Raut A; Rybak MJ
Antimicrob Agents Chemother; 2015 May; 59(5):2842-8. PubMed ID: 25753639
[TBL] [Abstract][Full Text] [Related]
22. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
[TBL] [Abstract][Full Text] [Related]
24. In vivo activity of a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, ceftaroline, against vancomycin-susceptible and -resistant Enterococcus faecalis strains in a rabbit endocarditis model: a comparative study with linezolid and vancomycin.
Jacqueline C; Caillon J; Le Mabecque V; Miègeville AF; Ge Y; Biek D; Batard E; Potel G
Antimicrob Agents Chemother; 2009 Dec; 53(12):5300-2. PubMed ID: 19752276
[TBL] [Abstract][Full Text] [Related]
25. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
Dowzicky MJ; Park CH
Clin Ther; 2008 Nov; 30(11):2040-50. PubMed ID: 19108792
[TBL] [Abstract][Full Text] [Related]
26. Inhibitory and bactericidal effects of telithromycin (HMR 3647, RU 56647) and five comparative antibiotics, used singly and in combination, against vancomycin-resistant and vancomycin-susceptible enterococci.
Baltch AL; Smith RP; Ritz WJ; Bopp LH
Chemotherapy; 2001; 47(4):250-60. PubMed ID: 11399861
[TBL] [Abstract][Full Text] [Related]
27. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
[TBL] [Abstract][Full Text] [Related]
28. Comparative evaluation of penicillin, ampicillin, and imipenem MICs and susceptibility breakpoints for vancomycin-susceptible and vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
Weinstein MP
J Clin Microbiol; 2001 Jul; 39(7):2729-31. PubMed ID: 11427608
[TBL] [Abstract][Full Text] [Related]
29. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
Arias CA; Singh KV; Panesso D; Murray BE
Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
[TBL] [Abstract][Full Text] [Related]
30. Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.
Protonotariou E; Dimitroulia E; Pournaras S; Pitiriga V; Sofianou D; Tsakris A
J Hosp Infect; 2010 Jul; 75(3):225-7. PubMed ID: 20381193
[TBL] [Abstract][Full Text] [Related]
31. A novel high-resolution melting analysis approach for rapid detection of vancomycin-resistant enterococci.
Ozbak HA
Ann Saudi Med; 2018; 38(3):200-207. PubMed ID: 29848938
[TBL] [Abstract][Full Text] [Related]
32. Activity of trovafloxacin (with or without ampicillin-sulbactam) against enterococci in an in vitro dynamic model of infection.
Zinner SH; Gilbert D; Dudley MN
Antimicrob Agents Chemother; 1998 Jan; 42(1):72-7. PubMed ID: 9449263
[TBL] [Abstract][Full Text] [Related]
33. Presence of the resistance genes vanC1 and pbp5 in phenotypically vancomycin and ampicillin susceptible Enterococcus faecalis.
Schwaiger K; Bauer J; Hörmansdorfer S; Mölle G; Preikschat P; Kämpf P; Bauer-Unkauf I; Bischoff M; Hölzel C
Microb Drug Resist; 2012 Aug; 18(4):434-9. PubMed ID: 22524613
[TBL] [Abstract][Full Text] [Related]
34. Different VanA Elements in E. faecalis and in E. faecium Suggest at Least Two Origins of Tn1546 Among VRE in a Brazilian Hospital.
Merlo TP; Dabul AN; Camargo IL
Microb Drug Resist; 2015 Jun; 21(3):320-8. PubMed ID: 25588068
[TBL] [Abstract][Full Text] [Related]
35. Resistance of enterococci to ampicillin and glycopeptide antibiotics in Italy. The Italian Surveillance Group for Antimicrobial Resistance.
Fontana R; Ligozzi M; Mazzariol A; Veneri G; Cornaglia G
Clin Infect Dis; 1998 Aug; 27 Suppl 1():S84-6. PubMed ID: 9710675
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic resistance and virulence traits in clinical and environmental Enterococcus faecalis and Enterococcus faecium isolates.
Rathnayake IU; Hargreaves M; Huygens F
Syst Appl Microbiol; 2012 Jul; 35(5):326-33. PubMed ID: 22742879
[TBL] [Abstract][Full Text] [Related]
37. Ceftaroline restores daptomycin activity against daptomycin-nonsusceptible vancomycin-resistant Enterococcus faecium.
Sakoulas G; Rose W; Nonejuie P; Olson J; Pogliano J; Humphries R; Nizet V
Antimicrob Agents Chemother; 2014; 58(3):1494-500. PubMed ID: 24366742
[TBL] [Abstract][Full Text] [Related]
38. Time-kill profiles of Enterococcus to antibiotics used for intravitreal therapy.
Kowalski RP; Karenchak LM; Warren BB; Eller AW
Ophthalmic Surg Lasers; 1998 Apr; 29(4):295-9. PubMed ID: 9571661
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility patterns of enterococci causing infections.
Oncu S; Punar M; Eraksoy H
Tohoku J Exp Med; 2004 Jan; 202(1):23-9. PubMed ID: 14738321
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
